For the first time since it launched in 2020 and began accepting submissions in 2022, a program started by the FDA to provide support for unconventional drug development tools has accepted its first ...
Mood disorders like major depressive disorder (MDD) and bipolar disorder are often complex and hard to diagnose, especially among youth when the illness is just evolving. This can make decisions about ...
MONTREAL — Pathway today announced the launch of a fully integrated drug reference and drug-drug interaction checker within its AI-powered medical knowledge platform. Clinicians can now access ...
FORT COLLINS, Colo.--(BUSINESS WIRE)--VetDC, Inc., today announced that the company has acquired from Pathway Therapeutics, Inc. all rights to Pathway’s investigational class of anti-cancer molecules, ...
Nature Genetics article uses yeast model to mimic connections in Parkinson’s disease. Using a new algorithm called ResponseNet that combines existing data to produce a chart of how cells respond to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback